High-Density Lipoprotein Mimetics: Focus on Synthetic High-Density Lipoprotein

American Journal of Cardiology

Volumn 100, Issue 11 SUPPL. 1, 2007, Pages

  Shah, Prediman K ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; HUMANS; RECOMBINANT PROTEINS;

EID: 36448975243     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.09.081     Document Type: Article

References (23)

1. Pal M., and Sivaram P. HDL elevators and mimetics-emerging therapies for atherosclerosis. Cardiovascular & Hematology Agents in Medical Chemistry 5 (2007) 55-66
2. Shah P.K., Kaul S., Nilsson J., and Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins. Circulation 104 (2001) 2498-2502
3. Price M.J., and Shah P.K. New strategies in managing and preventing atherosclerosis: focus on HDL. Rev Cardiovasc Med 3 (2002) 129-137
4. Forrester J.S., and Shah P.K. Emerging strategies for increasing high density lipoprotein. Am J Cardiol 98 (2006) 1542-1549
5. Thompson M.M., Reed S.C., and Cockerill G.W. Therapeutic approaches to raising plasma HDL-cholesterol levels. Nat Clin Pract Cardiovasc Med 1 (2004) 84-89
6. Kaul S., and Shah P.K. ApoA-I Milano/phospholipid complexes emerging pharmacological strategies and medications for the prevention of atherosclerotic plaque progression. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 471-479
7. Shah P.K. Apolipoprotein A-I/HDL infusion therapy for plaque stabilization-regression: a novel therapeutic approach. Curr Pharm Des 13 (2007) 1031-1038
8. Shah P.K. Pathogenesis of atherosclerosis. In: Rosendorf C. (Ed). Essential Cardiology: Principles and Practice (2004), W. B. Saunders Company, Philadelphia
9. Llodra J., Angeli V., Liu J., Trogan E., Fisher E.A., and Randolph G.J. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A 101 (2004) 11779-11784
10. Sumi M., Sata M., Miura S., Rye K.A., Toya N., Kanaoka Y., Yanaga K., Ohki T., Saku K., and Nagai R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol 27 (2007) 813-818
11. Tso C., Martinic G., Fan W.H., Rogers C., Rye K.A., and Barter P.J. High-density lipoproteins enhance progenitor-mediated endothelium repair in mice. Arterioscler Thromb Vasc Biol 26 (2006) 1144-1149
12. Franceschini G., Sirtori C.R., Capurso A., Weisgraber K.H., and Mahley R.W. A-I Milano apoprotein: decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66 (1980) 892-900
13. Ameli S., Hultgardh-Nilsson A., Cercek B., Shah P.K., Forrester J.S., Ageland H., and Nilsson J. Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90 (1994) 1935-1941
14. Milano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ Res 76 (1995) 405-411
15. Milano on aortic atherosclerosis in apolipoprotein E-deficient mice. Circulation 97 (1998) 780-785
16. Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Circulation 103 (2001) 3047-3050
17. Milano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 90 (2002) 974-980
18. Choudhury R.P., Rong J.X., Trogan E., Elmalem V.I., Dansky H.M., Breslow J.L., Witztum J.L., Fallon J.T., and Fisher E.A. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation. Arterioscler Thromb Vasc Biol 24 (2004) 1904-1909
19. Milano-phospholipid complex. J Am Coll Cardiol 44 (2004) 1311-1319
20. Milano/phospholipid complex (ETC-216) inhibits in-stent stenosis in porcine coronary arteries. Circulation 107 (2003) 2551-2554
21. Nissen S.E., Tsunoda T., Tuzcu E.M., Schoenhagen P., Cooper C.J., Yasin M., Eaton G.M., Lauer M.A., Sheldon W.S., Grines C.L., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
22. Tardif J.C., Grégoire J., L'Allier P.L., Ibrahim R., Lespérance J., Heinonen T.M., Kouz S., Berry C., Basser R., Lavoie M.A., Guertin M.C., Rodés-Cabau J., and Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis. JAMA 297 (2007) 1675-1682
23. Wang L., Sharifi B.G., Pan T., Song L., Yukht A., and Shah P.K. Bone marrow transplantation shows superior atheroprotective effects of gene therapy with apolipoprotein A-I Milano compared with wild-type apolipoprotein A-I in hyperlipidemic mice. J Am Coll Cardiol 48 (2006) 1459-1468